Andrew F. Leuchter, MD, is Professor and Executive Vice Chair of the Department of Psychiatry and Biobehavioral Science, Director of the TMS Clinical and Research Program and the Neuromodulation Division, and Associate Director of the Semel Institute for Neuroscience and Human Behavior at UCLA. A graduate of Stanford University, Dr. Leuchter earned his medical degree from Baylor College of Medicine in Houston, Texas. He joined the UCLA faculty in 1986.
An internationally recognized expert on the treatment of mood disorders, Dr. Leuchter’s research focuses on the enhancement of treatment outcomes in depression. He is leading clinical trials to improve TMS treatment outcomes and develop novel technologies for treatment of depression and Post-Traumatic Stress Disorder (PTSD), including synchronized Transcranial Magnetic Stimulation (sTMS) and Trigeminal Nerve Stimulation (TNS). He uses brain-imaging techniques, such as quantitative electroencephalography (qEEG) and magnetic resonance imaging (MRI) to examine brain function and predict which treatments are most likely to benefit individual patients.
Dr. Leuchter is a Diplomat of the American Board of Psychiatry and Neurology as well as the American Board of Electroencephalography and Neurophysiology. He is a member of several professional organizations, including the American Psychiatric Association, the Clinical TMS Society, and the American Medical EEG Association. He has authored over 150 scientific articles on topics including neuromodulation for the treatment of depression, biomarkers to guide treatment of neuropsychiatric illness, and theories of antidepressant action. He also maintains an active clinical practice, specializing in consultation for and care of patients suffering from treatment-resistant depression.
For more information on Dr. Leuchter, please visit: www.andrewleuchter.com
